Statens legemiddelverk — Norwegian Medicines Agency Shortages (NOMA)

Statens legemiddelverk — Norwegian Medicines Agency Shortages is the official source of medicine shortage information for Norway (Europe). Mederti checks its register daily and links every notice back to the original publication.

Official register

legemiddelverket.no

Country

Norway

Notices tracked by Mederti

1,482

Last checked

1 Nov 2026

Latest notices from NOMA

• Jern(Ii)Sulfat, Tørret — anticipated, medium, since 1 Sept 2027 (source)
• Aprepitant — anticipated, medium, since 15 Mar 2027 (source)
• Fentanylsitrat — anticipated, medium, since 31 Jan 2027 (source)
• Salbutamolsulfat — anticipated, medium, since 4 Jan 2027 (source)
• Pomalidomida Teva — anticipated, medium, since 1 Jan 2027 (source)
• Chikungunyavirus, Stamme Chikv Lr2006-Opy1, Helt, Attenuert — anticipated, medium, since 31 Dec 2026 (source)
• Dutasteride; Tamsulosin — anticipated, medium, since 28 Dec 2026 (source)
• Tauroselkolsyre — anticipated, medium, since 24 Dec 2026 (source)
• Difteritoksoid, Clostridium Tetani, Toksoid, Pertussistoksoid, Filamentøst Hemagglutinin, Pertaktin, Poliovirus Type 1, Inaktivert, Poliovirus Type 2, Inaktivert, Poliovirus Type 3, Inaktivert — anticipated, medium, since 22 Dec 2026 (source)
• Betametasona — anticipated, medium, since 19 Dec 2026 (source)
• Paracetamol — anticipated, medium, since 14 Dec 2026 (source)
• Atovakvon, Proguanilhydroklorid — anticipated, medium, since 1 Dec 2026 (source)
• Lantankarbonathydrat — anticipated, medium, since 1 Dec 2026 (source)
• Trabektedin — anticipated, medium, since 1 Dec 2026 (source)
• Pomalidomida Teva — anticipated, medium, since 1 Dec 2026 (source)

Mederti is not affiliated with or endorsed by Statens legemiddelverk — Norwegian Medicines Agency Shortages. All notices remain the property of their publisher and are linked to the original source.